INTRODUCTION
Regulation of antibody synthesis and of lymphocytes involved in the immune response has been proposed by Jerne (1) to be controlled by a network of antibodies and lymphocytes. Antiidiotypic antibodies directed against cell-surface receptors or secreted idiotypic molecules have been shown to be important elements in transplantation tolerance or the specific suppression of an antibody response (2, 3) . Antiidiotypic antibodies that recognize and regulate the expression of idiotypic determinants on the cell surface could theoretically play a key role in the induction of self-tolerance and the prevention of autoimmunity. Abnormalities in the idiotype antiidiotype system could therefore lead to expression or expansion of autoreactive cell clones (4) (5) (6) .
Self-tolerance is also dependent on suppressor cells (7) . Suppressor cell dysfunction could in part be responsible for autoantibody production in systemic lupus erythematosus (SLE)1 (8, 9) . In fact, there appears to be a close interplay between suppressor cells and the idiotypic network in the regulation of the immune response (10) (11) (12) .
In this study we have tested an extension of the net-'Abbreviation used in this paper: SLE, systemic lupus erythematosus.
work theory (1) with respect to modulation of the expression ofautoantibody activity by presumed antiidiotypic factors. We have demonstrated the presence of autoantiidiotypic antibody in sera of inactive SLE patients. In normal individuals who have had contact with lupus material, we found a cross-reacting antiidiotypic antibody against double-stranded DNA antibody. The effector activity is present in the F(ab')2 portion of immunoglobulin (Ig)G from sera of inactive SLE patients; it binds more avidly to autologous anti-DNA antibody than to antibody from unrelated donors. The blocking antibody could not inhibit an unrelated antigen-antibody reaction and could not be detected in sera of active SLE patients or in sera of normal individuals not exposed to lupus sera. METHODS Patients and controls. 19 patients who satisfied the American Rheumatism Association preliminary diagnostic criteria for SLE (13) were studied. 19 normal healthy individuals without personal or family history suggestive of an autoimmune state and with normal levels (<6.4% binding) of serum anti-DNA antibody were used as controls. 5 of the 19 normal individuals had contact with lupus patients and sera for varying periods of time (0.5-16 yr), and the other 14 normals had no contact with lupus material. The study was approved by the institution's human subjects committee and informed consents were obtained from all of the subjects who entered the study. All patients were studied twice, when their disease was active and again during clinical remission. Patients were considered to have active disease if organ-specific clinical symptoms plus at least two of the following laboratory criteria were present: (a) erythrocyte sedimentation rate > 25 mm/h; (b) total hemolytic complement CH50 < 120 U; (c) DNA antibodies > 14% binding. Patients were considered to have inactive disease if no organ-specific clinical symptoms or signs could be elicited and if the laboratory criteria-erythrocyte sedimentation rate, CH50, DNA antibodies-were within the normal range. None of the patients was on cytotoxic drugs. Prednisone dosage received by patients during active disease ranged from 5 to 6 mg/d (mean, 32.5 mg), and during inactive disease, from 0 to 40 mg/d (mean, 25 mg/d).
Serum complement determination (CH50 assay) was done by a standard technique. The binding of sera to native DNA was studied by the Millipore filter radioimmunoassay (Millipore Corp., Bedford, Mass.) using human KB cell line [3H]DNA (Electro-Nucleonics, Inc., Fairfield, N. J.) (14) .
Adsorption of anti-DNA antibody on DNA-cellulose columns. Calf thymus DNA-cellulose (Worthington Biochemical Corp., Freehold, N. J.) was suspended in buffer (0.01 M Tris-HCl, 0.001 M EDTA, pH 7.4), and packed in columns (K9/15 columns, Pharmacia Fine Chemicals, Uppsala, Sweden). For each 2 g of DNA-cellulose (containing 18 mg DNA), 10 ml of serum was allowed to pass through the column at 4°C at a rate of 2 drops/min. The effluents were passed again through the DNA-cellulose columns to insure complete removal of the anti-DNA antibody. Sera treated in this manner did not contain any detectable anti-DNA antibody (0% binding) when tested by radioimmunoassay (14) . Cellulose columns to which no DNA was coupled were incapable of depleting anti-DNA antibody. Suppression of anti-DNA binding to [3H]DNA by blockinig sera or immunoglobulin fragments and testing of precipitate formation by Clq-binding assay. All sera to be tested for the presence of anti-anti-DNA antibody (antiidiotypic or blocking antibodies) were depleted of anti-DNA antibody by passage twice through DNA-cellulose columns and then treated with 6 U of DNAse-Sepharose to digest DNA. In preliminary experiments, lupus sera with 90% DNA-binding capacity or with 10 ,g DNA/ml could be completely depleted by this treatment. None of the blocking sera used in these experiments had DNA-binding capacity > 90% or DNA > 10 ,ug/ml. Adequacy of depletion was confirmed by the failure to detect anti-DNA antibody by radioimmunoassay (14) and of DNA by chromatography (15) . The anti-DNA depleted and DNAsetreated sera (blocking sera) were assayed for their capacity to inhibit the binding of [3H]DNA to sera from active lupus patients (target sera). For the blocking assay 100 Al containing 1 nmol of the blocking material IgG or its various fragments was incubated with 100 ,l of a target serum (containing 1 nmol IgG) at 370C for 1 h and then for 16 h at 4°C.
The mixtures were centrifuged at 1,000 g for 30 min; 100 AId of the supernate was collected and tested in the standard DNA-binding assay (14) . The remaining 100 ,lI, designated the precipitate fraction, was tested in a conventional Clq binding assay (16) .
The percent suppression of DNA binding was calculated from the formula:
DNA binding of mixtures of target (1 -and blocking sera x 100.
\ DNA binding of target sera alone J Depletion of various Ig classes. Depletion of serum IgG, IgM, or IgA was performed by standard techniques as described earlier (17) . Adequacy of depletion was confirmed by immunoelectrophoresis and by immunodiffusion.
Preparation of IgG, F(ab)'2, and Fc fragments. IgG proteins were isolated from serum by affinity chromatography on Protein A-Sepharose 4B (Pharmacia Fine Chemicals, Uppsala, Sweden). F(ab')2 fragments produced by pepsin digestion of IgG proteins were separated from Fc-containing materials by passing over a column of Protein A-Sepharose 4B (18) . Fab and Fc fragments, which were produced by papain digestion of IgG proteins, were separated also by Protein A-Sepharose 4B chromatography (18) . These IgG fragments were separately passed through a column of Sephadex G-150 to ensure the removal of undigested IgG proteins. IgG and its enzymatic cleavage fragments thus prepared were immunologically pure and distinct when examined by immunoelectrophoresis.
Preparationi of F(ab')2 fragnmenits from active luptus sera. To enisture that the blocking activity of the antiidiotypic antibody is directed towards the binding sites of anti-DNA antibody, we prepared F(ab')2 fragments from IgG isolated firomi active Itipsis sera. The isolation of'IgG proteins on Protein A-Sepharose 4B and(l the preparation of F(ab')2 fragmenits by pel)psin digestion were as described above.
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N. I. Abdou, H. Wall, H. B. Linidsley, J. F. Halsey, anid T. Suzuki PreparationI of nIormall gaininIaglobutlitn iimunl tl 1oadsorbents. To enisuire the specificity of' the acntiidiotypic acntibody, we atteml)ted to dep)lete its blocking activity by passinlg it throuigh normiial gani magloblt in immu1niioacldsorbenit columniiiis. Galmmmaglobuilins were isolated f'rom five different normiial sera by 33% am miionimmiiiilf,lf'ate precipitation. The precipitate was washed, dialyzed, redissolveci, aind covalently couipled to CNBractiviatedl Sepharose 4B according to the method described by Marchl et al. (19) . Suelh affinity chromatography media were dleniotedl aIs gain maglobul in ininntunoadsorbents. Aliquiots of one antiidiotypic serumii -prepared f'rom iniactive lulptus serulm as described above-were allowed to pass throuigh the five dif'ferent iinmtinoadsorbents. The blocking activity of' the antiidiotyvic sertiimi was tested before acnd after its passage tlhrouigh the vatriouis iimmuntiioadsorbenits.
Heinagglutitt(tioni assaiy. To test f'or specificity of the autoantiidiotypic antibody, serulm from aI normiial clonor who haldl recenitly been l)oosted with tetainuts toxoid was uised as the target serumlli. Anltitetanutls antibody was assayed by the staidlardl passive hemllaggluitnlation assay uisinlg chromiumiin clhloride to coat slheep erythrocytes with tetanuis toxoid (20) .
Statisticail an(lylsis. The paired t test was uised to compare suppression of' target sera in the presence or absence of blocking sera. For comIparison of percent suippression with Clq binding, the Spearmiian raink correlation coefficient was caleulatedl (21) .
RESULTS
Blockitng of atnti-DNA binding. Autologous sera from lupups patienits with inactive disease (n = 19) were found to suippress the binding of [3H]DNA to the target lupus sera (P < 0.01) ( Fig. 1 , Table I ). Blocking sera from active unrelated (n = 9), from active autologous (n = 19), or from inactive unrelated (n = 9) lupus patients were not capable of suppression. Human serunm albumin at a similar protein concentration and processed similarly to the various blocking sera was also incapable of suppression ( Fig. 1 ). The mean suppression value of the 19 by themselves (P = 0.2) ( Fig. 1 , Table I ). However, normal sera from donors who had contact with lupus patienits and iupus blood components had significant suppressive activity on the target active lupus sera (P < 0.02) (Tables I and II) . Sera from normal donors who had no contact with lupus material did not suppress (P > 0.5) (Table II) . Clq binding correlated with suppression of DNA binding. Precipitate fractions obtained from incubating F(ab')2 fragments with the corresponding autologous target sera were tested for their ability to bind 1251. Clq by radioimmunoassay. The upper limits of the 95% confidence intervals for individual values of fragments from active lupus sera are shown with dotted lines parallel to each axis (25% for suppression, 8% for Clq binding) (Fig. 2 ). Low Clq binding values (3-7%) occurred with sera and fragments from active lupus patients; higher Clq binding values (8-34%) occurred with those from patients with inactive lupus (Fig. 2) . When samples from patients with active and inactive disease were considered together, percent suppression correlated significantly with Clq binding (Spearman's rho = 0.92, P < 0.01).
Effects of immunoglobulin depletion of the blocking sera. In the five experiments performed on five different sera, depletion of IgG eliminated the suppressive capacity of the autologous inactive lupus serum (Fig. 3 ). Depletion of IgM or of IgA failed to do so (P < 0.01).
Failure of depletion of the blocking activity by adsorption on normal human gammaglobulin. To avoid artefacts upon IgG depletion of blocking sera by immunoadsorbents, it is shown in Table III that normal gammaglobulin immunoadsorbents from five different donors failed to deplete the blocking activity of the lupus serum.
Effects of IgG fragments on DNA binding. In the nine sera that were processed and tested, F(ab')2 fragments and not Fc fragments of the inactive lupus sera were capable of suppressing the binding of anti-DNA antibody to [3H]DNA (P < 0.001) ( Fig. 4) . Fab fragments (P < 0.02), whole serum (P < 0.01), and globulin fractions (P < 0.01) were also inhibitory.
Effects of the blocking IgG on binding of F(ab')2 fragments of the active lupus IgG to [3H]DNA.. To ensure that the blocking activity of the inactive autologous IgG is directed towards the binding sites of the anti-DNA antibody, we have prepared F(ab')2 fragments from IgG of five different active lupus sera. It could be seen from Table IV that the blocking IgG inhibited the binding of the F(ab')2 fragments to [3H]-DNA. Fc fragments prepared from the same active lupus sera failed to bind to [3H]DNA in the absence or presence of the blocking IgG (not shown in Table IV ).
Effect of IgG fragments on tetanus toxoid binding. Whole serum, globulin fraction, or the various IgG frag-Suppression of Anti-DNA Antibody by Antiidiotypic Antibody ments ofthe same nine inactive lupus sera tested above made up of lymphocyte clones capable of binding to a for their anti-anti-DNA antibody activity did not inhibit multitude of antigens (22) . During ontogeny, selfthe antitetanus antibody binding to tetanus toxoid as reactive (forbidden) clones were thought to be detested by a hemagglutination technique (Fig. 5 ). stroyed and the surviving clones were believed to be directed mainly against nonself antigens (22) . How-DISCUSSION ever, a number of recent important findings have re-The clonal selection theory has prevailed for many vealed new complexities. Self-reactive clones could be years and has suggested that the immune system is detected in normal individuals (23, 24) . The discovery Clq binding was measured on a precipitate fraction formed by the interaction of lupus F(ab')2 with autologous target serum (see Methods). Percent suppression of DNA binding was determined on the same assay tubes. The upper limit of the 95% confidence interval, for the samples from patients with active disease only, are shown as dotted lines parallel to the corresponding axis. There was a significant correlation (Spearman's rho = 0.92, P < 0.01) between Clq binding and the degree of stuppression of DNA binding. F(ab')2 fragmllents from sera of active patients clustered in the lower left quadrant and were easily distinguished from those with inactive disease. of positive and negative interactions between T and B lymphocytes (7) and the possible involvement of idiotypes in clonal interactions (4) indicate that the immune system can recognize selfand is regulated by a complex idiotypic network (1) (2) (3) (4) (5) . Idiotypes and autoantiidiotypes coexist in the repertoire of a single individual; autoantiidiotypes can be induced or occur spontaneously during the immune response (4, (25) (26) (27) . These antiidiotypic antibodies can exert either positive or negative influences on antibody biosynthesis or on effector cell function (10, 27 In this report we have examined the modulation of autoantibody activity by means of antiidiotypic antibodies. We have demonstrated that binding of anti-DNA antibody to DNA could be blocked by F(ab')2 and Fab fragments of IgG obtained from autologous sera of inactive lupus patients (Fig. 4 ). Blocking activity was probably due to occupancy of the combining site, since Fc fragments of the same IgG had no blocking activity. We have not ruled out, however, the possi- binding in absence of blocking IgG bility that blocking is due to anti-light chain activity, or due to DNA fragments present in the inactive lupus serum. We have ruled out the possibility that the blocking factor is due to rheumatoid factor activity, since the former was capable of blocking the binding of F(ab')2 fragments of the active lupus sera (Table IV) . It is unlikely that the suppressed activity of the anti-DNA antibody was due to its aggregation upon overnight incubation, since sera incubated without the blocking material and processed in an identical manner had similar DNA-binding activity to that before incubation. The anti-anti-DNA activity could not be detected in active lupus sera (Fig. 1) , could not be adsorbed by normal human gammaglobulin (Table III) , could not block an unrelated antigen-antibody reaction (Fig. 5 ), and was directed towards F(ab')2 fragments of the anti-DNA antibody (Table IV) . Sera from normal donors who had contact with lupus patients and lupus blood components had anti-anti-DNA activity, indicating the probable presence of cross-reacting antiidiotypic antibodies in their sera (Table I) . Specificity of the blocking activity of the normal sera for the Fab portion of IgG was not tested. Inhibition of anti-DNA binding by normal human serum has been observed previously (28) . The factors responsible for the production of the cross-reacting (nonautologous) antiidiotypic antibodies in the normal donors who had contact with lupus materials are unknown. This could reflect a regulatory mechanism in a normal protective immune response. Lymphocytotoxic antibodies and antinuclear antibodies (29), but not Sm antibodies (30) , have been found in families of lupus patients. Laboratory personnel in contact with lupus materials have increased levels of lymphocytotoxic antibodies (31), but not anti-double-stranded DNA antibodies (Table I) . Failure to detect specific serum antibodies (anti-DNA, anti-Sm) in family members and normals in contact with lupus materials could be attributed to an efficient regulation by an autoantiidiotypic antibody and/ or the lack of a particular immune response gene for the development of the disease (32) .
The formation of immune precipitates upon binding of anti-DNA antibody to the antiidiotypic antibody was tested by the Clq binding assay. F(ab')2 fragments from IgG of four patients with inactive disease clearly exceeded the calculated range for fragments from patients with active lupus (Fig. 2) . We presume that the radioiodinated Clq is binding an immune precipitate, although we have no direct proof that this is so. A solidphase Clq binding assay or Raji cell assay would permit direct evidence, since a radioiodinated anti-IgG antibody is used to detect an immune complex.
The interplay and the complexity ofthe various regulatory mechanisms in autoimmunity have been discussed (4, 5, 33) . In active SLE, suppressor T cells are deficient or dysfunctional (8, 34, 35) . In inactive SLE, suppressor T cells are capable of inhibiting immunoglobulin and anti-DNA antibody secretion (34) . The same suppressor cells collected from inactive SLE patients are, however, incapable of affecting the number of DNA-binding autoreactive clones (34 liminary results indicate that the autoantiidiotypic antibody, in the presence of guinea pig complement, is capable of killing DNA-binding B cells (36) . Based on these findings, we propose that there are two levels of regulation ofanti-DNA antibody in SLE: one modulated by suppressor cells, and a second modulated by an antianti-DNA antibody. The factors responsible for the activation of suppressor cells and for autoantiidiotypic antibody production in the inactive SLE state are unknown. Clearer understanding of all the regulatory elements awaits the completion of critical and reproducible studies dealing with the role of exogenous infectious agents, genetic and hormonal factors that might participate in the pathogenesis of SLE.
